Although the proliferative tumor-matching cytotoxic CD4+ T cells in blood are of interest for their putative tumor recognition, how they map onto specific GZMB- or GZMK-expressing subsets, and more generally the ontological relationship between distinct granzyme-expressing populations, has not been explored. The gene discussed is GZMK; the disease is neoplasm.